-
Autism Tsunami: The Impact of Rising Prevalence on the Societal Cost of Autism in the United States
Abstract As the rates of diagnosed autism spectrum disorders (ASD) reach unprecedented levels, numerous analyses have attempted to model, quantify, and forecast the societal cost of ASD at the country level. These forecast models focus on costs…
-
Evidence-Based Evaluation of PCR Diagnostics for SARS-CoV-2 and the Omicron Variants by Gold Standard Sanger Sequencing
Abstract Both SARS-CoV-2 and SARS-CoV-1 initially appeared in China and spread to other parts of the world. SARS-CoV-2 has generated a COVID-19 pandemic causing more than 6 million human deaths worldwide, while the SARS outbreak quickly ended…
-
The Use of Arbitrary and Generalized Ct Values in COVID-19 Non-Quantitative Reverse Transcriptase Polymerase Chain Reaction (nonQ-RT-PCR) Testing Must End
Editorial An elementary problem with the polymerase chain reaction (PCR) – recognized at its inception – is that non-specific binding of PCR primers to arbitrary targets will cause off-target amplification. This is true whether the target sequence…
-
COVID-19 Illness and Vaccination Experiences in Social Circles Affect COVID-19 Vaccination Decisions*
Abstract Policymakers have communicated that COVID-19 vaccination programs need to be accepted by a large proportion of the population to allow life to return to normal. However, according to the Center for Disease Control and Prevention, about…
-
Access to Hydroxychloroquine Is Associated with Reduced COVID-19 Mortality: A Cross-Country Analysis
Abstract Over the last two and a half years the world experienced the severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic coupled with unprecedented policy responses. In this article we examine the determinants of COVID-19 infections and…
-
Critical Appraisal of VAERS Pharmacovigilance: Is the U.S. Vaccine Adverse Events Reporting System (VAERS) a Functioning Pharmacovigilance System?
“Patterns of adverse events, or an unusually high number of adverse events reported after a particular vaccine, are called ‘signals.’ If a signal is identified through VAERS, scientist[s] may conduct further studies to find out if the…
-
The Safety of COVID-19 Vaccinations — Should We Rethink the Policy?
Abstract Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits. Methods: We calculated the Number Needed to Vaccinate (NNTV) to prevent one death from a large Israeli field…
-
If Vaccine Adverse Events Tracking Systems Do Not Support Causal Inference, then “Pharmacovigilance” Does Not Exist
Editorial There are two messages from those who hold appointed offices or other influential positions in Public Health on long-term vaccine safety. The first message is that long-term randomized double-blinded placebo-controlled clinical trials are not necessary for…
-
COVID-19 Data Collection, Comorbidity & Federal Law: A Historical Retrospective
Abstract According to the Centers for Disease Control and Prevention (CDC) on August 23, 2020, “For 6% of the deaths, COVID-19 was the only cause mentioned. For deaths with conditions or causes in addition to COVID-19, on…
-
Misapplication of the Precautionary Principle has Misplaced the Burden of Proof of Vaccine Safety
Abstract Vaccination is a medical intervention that comes with a risk for some people. In the expression of infectious diseases, it is known that the pathogen alone does not cause disease: it is a combination of the…
-
The Lies Vaccinologists Tell Themselves: VAERS Receives Due Scrutiny on Rating and COVID-19 VAERS Patterns Require Explanation
Editorial Two articles in Volume 2 address the question of detecting signals in the US Vaccine Adverse Events Reporting System (VAERS). Co-managed by the US CDC and the US FDA, VAERS is represented as having the strengths…
-
Significant Under-Reporting of Quadrivalent Human Papillomavirus Vaccine-Associated Serious Adverse Events in the United States: Time for Change?
Abstract The Vaccine Adverse Event Reporting System (VAERS) was created in 1 990 by the Center for Disease Control and Prevention (CDC) to track adverse events following inoculations (AEFIs). Less than 1% of AEFIs are reported and…
-
A Report on the U.S. Vaccine Adverse Events Reporting System (VAERS) of the COVID-19 Messenger Ribonucleic Acid (mRNA) Biologicals
Abstract Following the global roll-out and administration of the Pfizer/BioNTech (BNT1 62b2) and Moderna (mRNA-1 273) COVID-19 vaccines1 on December 17, 2020 in the United States, and of the Janssen COVID-19 Vaccine PF (produced by Johnson &…
-
Excess Teen Suicide Risk Associated with GardasilTM Exposure: Implications for Public Health Policy
Abstract There are likely but hitherto unreported safety signals for GardasilTM vaccine in the form of increased risk of suicides and deaths from all causes in clinical trial group exposed to the Gardasil vaccine. Comparison of suicide…
-
Measles Outbreak Exposes National Security Readiness Problems and False Narratives
Editorial The corporate proponents of vaccine products are promoting their use to the U.S. Government as a tool for promoting national security. There are quite a few factors that make these claims dubious at best. Among the…
-
Shortcomings in the Latest MMR Vaccination and Autism Study: A Healthcare Administrator’s Response
Abstract While the autism rate continues to climb among school age children and younger, regulatory agencies continue to fumble the critical responsibility of proper testing of vaccines for safety. The problems are numerous. Here we look at…
-
Our Flawed Mental Health Policies and Their Possible Link to the Disastrous State of Mental Health in America
Abstract Mental Health policy in America should address the growing need to help people live the happiest and best life possible, and support them in getting there. Recovery from mental health issues is founded on the principle…
-
Science, Public Health Policy & the Law: Convergence.
Editorial To say some particular conjecture is ”scientific knowledge” presumes that the conclusions drawn are based on valid studies via which a chain of evidence has been produced in objectivity, without intentional or unintentional bias. In reality,…
-
A Novel Approach to Treating COVID-19 Using Nutritional and Oxidative Therapies
Abstract Objective: This report is a case series of consecutive patients diagnosed with COVID-19 treated with a nutritional and oxidative medical approach. We describe the treatment program and report the response of the 107 COVID-19 patients. Study…
-
OPENING SALVO – THE FUTURE OF SCIENCE AND MEDICINE IS OURS
Part 1. THE FUTURE OF SCIENCE IS OURS James Lyons-Weiler, BA, MS, PhD and Peter A. McCullough, MD, MPH join forces with an army of ethical physicians and scientists to say: No More. As Founding Editor-in-Chief of…
-
On Call: A Critical Examination of Fauci’s Public Service Narrative
In “On Call: A Doctor’s Journey in Public Service,” Anthony Fauci endeavors to chart his impressive career, from his early battles against the AIDS epidemic to the fraught days of the COVID-19 pandemic. At first glance, the…
-
Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids: Biologic Plausibility and Potential Consequences
Abstract Exposure to lipid nanoparticles, modified mRNA, adenoviral DNA, and/or spike protein from a Covid-19 injectable product or through secondary exposure via blood transfusion, is a potential source of human physiological harm. Blood reactions are an acknowledged…
-
Batch-dependent Safety of the BNT162b2 mRNA COVID-19 Vaccine in the United States
Research Letter This research letter adds to a recent publication from Schmeling, Manniche, and Hansen (2023) [1] that identified unexpected, batch-dependent suspected adverse events (SAEs) following Pfizer’s BioNTech’s BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). The study associated vaccine…
